Skip to main content
Clinical Trials/NCT00978861
NCT00978861CompletedPhase 3

A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate of The Whitening Efficacy and Safety of REMEWHITE

JDC Tech1 site in 1 country70 target enrollmentStarted: October 2008Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
70
Locations
1
Primary Endpoint
colorimeter

Study Overview

Brief Summary

The purpose of this study is to determine the effect of REMEWHITE on tooth whitening.

Detailed Description

This study intended to establish the efficacy of REMEWHITE after using the product under controlled conditions at the hospital.

The efficacy of the product was assessed at the end of the study; clinical examination by the dentist.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • ability to understand and provide informed consent
  • general good health male and female adults, were 20 years or older
  • no pregnant woman
  • had six caines-free maxillary anterior teeth without restorations on the labial surfaces

Exclusion Criteria

  • had severe internal discoloration (tetracycline stains, fluorosis, pulpless teeth)
  • evidence of fracture or major cracks on tooth
  • were pregnant or nursing
  • had tooth sensitivity
  • had teeth shade A1, A2

Arms & Interventions

whitening

Experimental

30% Hydrogen peroxide

Intervention: Hydrogen Peroxide (Drug)

Outcomes

Primary Outcomes

colorimeter

Time Frame: 12 weeks after treatment

Secondary Outcomes

  • colorimeter(24 weeks after treatment)

Investigators

Sponsor
JDC Tech
Sponsor Class
Industry

Study Sites (1)

Loading locations...

Similar Trials